Will Kids Get OK for COVID Shots?

Plus: What Inflation Means for Stocks You are receiving this limited-time email resource as a subscriber to Kiplinger's free e-newsletters. To unsubscribe at any time, simply click the link in the footer below. OCTOBER 25, 2021 [View in browser]( HOW TO PROTECT AND GROW YOUR BUSINESS AND INVESTMENTS NOW An expert advisory panel to the Food and Drug Administration will meet tomorrow to decide on a proposal to broaden Pfizer ([PFE]( and BioNTech’s ([BNTX]( COVID-19 vaccine’s Emergency Use Authorization to include children ages five to 11. Scientists at the FDA will present their conclusion that the benefits of the vaccine outweigh the risks of myocarditis, or heart inflammation. Data to be presented will show that the vaccine is 91% effective in preventing infection, and reduces the severity if infection does occur. The dosage level for this age group is one-third the adult level. The risk of myocarditis may be in the range of 1 in 5,000 to 1 in 12,000 for 16- and 17-year-old boys, but may be lower, at 1 in 24,000, for 12- to 15-year-old boys. Only one case out of 255,000 in an Israeli study was found in a girl. The FDA scientists argue that at least that many hospitalizations for COVID-19 would be prevented by the vaccine, and that those hospitalizations would be worse outcomes than those for myocarditis. --------------------------------------------------------------- SPONSORED CONTENT FROM LENDINGTREE [2 Minutes Online Could Save You Over $40K in Your Mortgage]( If you bought your home or last refinanced during a higher interest-rate environment, now could be a good time for you to refinance. Compare your best offers now. [READ MORE]( --------------------------------------------------------------- Inflation: Not that scary for stocks? If you’re a regular reader of investing media, you’re no doubt keenly aware of Wall Street's current obsession with the specter of rapidly rising prices. Indeed, many recent trading sessions appear to have keyed, at least partly, on inflation data and other price-related smoke signals. From the latest consumer and producer price index data releases, to Federal Reserve commentary on inflation expectations, the market has frequently been in thrall to this critical macroeconomic concern. But Ben Carlson, who manages portfolios at Ritholtz Wealth Management, says investors need to check their inflation anxiety. Although persistently higher inflation would seem to be a big risk to the stock market, there's no historical evidence that stocks suffer when prices are rising. You can [check out the charts and the rest of the blog post here]( but Carlson’s takeaway is that inflation might not be the bogeyman it’s made out to be. “If inflation is higher going forward than it had been in the recent past it’s not automatically a death sentence for the stock market,” he says. "And even when inflation has been as high or higher than it is right now, the stock market has held up pretty well in the past." Free download, [The Kiplinger Letter's Forecast](. No information required from you. SPONSORED CONTENT FROM 1440 MEDIA [Sick of Biased News Stories?]( Check out 1440—the fastest way to an impartial point of view. Their team scours 100+ news sources to catch you up in a single 5 minute email. Join for free! [READ MORE]( LATEST INVESTING NEWS FROM KIPLINGER.COM [Charitable Givers Dodge Draconian Parts of the Biden Tax Plan (So Far)]( [Medicare Basics: 11 Things You Need to Know]( [13 Safe Dividend Stocks to Buy]( [7 Best ETFs for Rising Interest Rates]( [Prosper with the Latest Insights from Practicing Financial Pros in Kiplinger's Building Wealth E-Newsletter -- Free]( [Kiplinger] [Facebook]( [Twitter]( [LinkedIn]( Send this to a friend. [Click here.]( All content ©2021 The Kiplinger Washington Editors 1100 13th Street, NW, Suite 1000 Washington, D.C. 20005 Thank you for subscribing to Kiplinger's A Step Ahead, a free resource to help readers navigate the economic recovery from COVID-19. If you ever wish to stop receiving this service, please [click here to unsubscribe](.